PubRank

Kun-Wei Shen

Author PubWeight™ 18.11‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Breast cancer in a transitional society over 18 years: trends and present status in Shanghai, China. Breast Cancer Res Treat 2009 1.49
2 Primary breast lymphoma: long-term treatment outcome and prognosis. Leuk Lymphoma 2006 1.49
3 Clinicopathological features of the triple-negative tumors in Chinese breast cancer patients. Breast Cancer Res Treat 2008 1.40
4 The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives. Breast Cancer Res Treat 2008 1.23
5 Development and trends of surgical modalities for breast cancer in China: a review of 16-year data. Ann Surg Oncol 2007 1.19
6 The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified. Breast Cancer Res Treat 2007 1.10
7 Progesterone receptor status provides predictive value for adjuvant endocrine therapy in older estrogen receptor-positive breast cancer patients. Breast 2007 1.00
8 Accuracy of MRI in prediction of pathologic complete remission in breast cancer after preoperative therapy: a meta-analysis. AJR Am J Roentgenol 2010 0.94
9 Triple-negative breast cancer types exhibit a distinct poor clinical characteristic in lymph node-negative Chinese patients. Oncol Rep 2008 0.92
10 Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives. Breast Cancer Res Treat 2008 0.92
11 Fiberoptic ductoscopy combined with cytology testing in the patients of spontaneous nipple discharge. Breast Cancer Res Treat 2007 0.87
12 Breast cancer in Chinese elderly women: pathological and clinical characteristics and factors influencing treatment patterns. Crit Rev Oncol Hematol 2009 0.86
13 Models for predicting BRCA1 and BRCA2 mutations in Han Chinese familial breast and/or ovarian cancer patients. Breast Cancer Res Treat 2008 0.84
14 Basal cytokeratin expression in relation to immunohistochemical and clinical characterization in breast cancer patients with triple negative phenotype. Tumori 2009 0.83
15 [BRCA1/2 gene mutation in Chinese familial breast cancer patients: a multi-center report of 115 cases]. Zhonghua Yi Xue Za Zhi 2008 0.80
16 Breast conservative therapy in east part of China: a retrospective cohort study. J Cancer Res Clin Oncol 2006 0.79
17 Neoadjuvant chemotherapy with vinorelbine-containing regimens in elderly patients with locally advanced breast cancer. Anticancer Res 2008 0.78
18 Accuracy of physical examination, ultrasonography, and magnetic resonance imaging in predicting response to neo-adjuvant chemotherapy for breast cancer. Chin Med J (Engl) 2012 0.77
19 [Advances in research on treatment of breast cancer with lapatinib]. Zhonghua Zhong Liu Za Zhi 2008 0.75
20 [Molecular classification of breast cancers]. Zhonghua Zhong Liu Za Zhi 2008 0.75
21 Addition of adjuvant tamoxifen to cyclophosphamide, methotrexate and 5-fluorouracil for premenopausal women with oestrogen receptor-positive breast cancer. Asian J Surg 2003 0.75
22 [A retrospective study of 129 cases with immediate breast reconstruction after skin-sparing mastectomy for breast cancer]. Zhonghua Wai Ke Za Zhi 2008 0.75